Literature DB >> 3803915

The cis-trans test shows no evidence for a functional relationship between two mouse t complex lethal mutations: implications for the evolution of t haplotypes.

P E Mains.   

Abstract

Mouse t haplotypes often carry embryonic lethal mutations. Sixteen complementation groups are known, but the viability of the heterozygotes between them is often less than 100%. It has been reported that cis heterozygotes of two lethal mutations showed better viability than trans heterozygotes. This could indicate that the mutations were part of the same functional unit, even though they map up to 15 cM apart. However, the tw5 and tw12 haplotypes in our colony did not show a statistically significant decrease in viability when combined in trans. The cis-trans analysis was repeated using two independent chromosomes, derived by recombination between the tw5 and the tw12 haplotypes to provide the two lethal mutations in cis. Two independent chromosomes, representing the reciprocal recombination event, supplied the corresponding wild-type alleles in cis. These chromosomes were combined in the four pairwise combinations, and male/female reciprocal crosses were done. The cis heterozygotes showed a decrease, rather than an increase, in viability in seven of the eight cases. These results probably reflect effects of unrelated background genes. The lethal mutations, instead of being functionally related, may have occurred in a random, unrelated set of genes and may confer a selective advantage to t haplotypes found in wild populations.

Entities:  

Mesh:

Year:  1986        PMID: 3803915      PMCID: PMC1203037     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  14 in total

1.  The Evolutionary Dynamics of a Polymorphism in the House Mouse.

Authors:  R C Lewontin; L C Dunn
Journal:  Genetics       Date:  1960-06       Impact factor: 4.562

2.  Pseudoallelism and gene evolution.

Authors:  E B LEWIS
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1951

3.  Selection in mice for change in viability of a semilethal genotype at the T locus.

Authors:  B J Klyde
Journal:  J Hered       Date:  1970 Jan-Feb       Impact factor: 2.645

4.  Cis-trans test shows a functional relationship between non-allelic lethal mutations in the T/t-complex.

Authors:  H S Shin; P McCormick; K Artzt; D Bennett
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  Gene mapping within the T/t complex of the mouse. I. t-Lethal genes are nonallelic.

Authors:  K Artzt; P McCormick; D Bennett
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

6.  A t-haplotype (tw75) overlapping two complementation groups.

Authors:  K Artzt; B Babiarz; D Bennett
Journal:  Genet Res       Date:  1979-06       Impact factor: 1.588

7.  A region flanking H-2K is duplicated to a distant site in most mouse t haplotypes.

Authors:  P E Mains
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Transmission ratio distortion in mouse t-haplotypes is due to multiple distorter genes acting on a responder locus.

Authors:  M F Lyon
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

9.  Inversion in the H-2 complex of t-haplotypes in mice.

Authors:  H S Shin; L Flaherty; K Artzt; D Bennett; J Ravetch
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

10.  Ip immunotherapy and chemotherapy in advanced epithelial ovarian cancer.

Authors:  E Hernandez; N B Rosenshein; J Pino y Torres; J Villar; F C Grumbine; D S Ettinger; M B Dillon; J L Klein; S E Order
Journal:  Cancer Treat Rep       Date:  1982-11
View more
  2 in total

1.  Distortion of transmission ratio by a candidate t complex responder locus transgene.

Authors:  L C Snyder; L M Silver
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Saturation germ line mutagenesis of the murine t region including a lethal allele at the quaking locus.

Authors:  A Shedlovsky; T R King; W F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.